Editorial: Current Progress and Challenges in the Development of a B Cell Based Hepatitis C Virus Vaccine

by Steven K. H. Foung, Thomas F. Baumert, Thomas F. Baumert, Thomas F. Baumert, Thomas F. Baumert
Published 2018-11-01

Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma

by Thomas F. Baumert, Yujin Hoshida
Published 2019-05-01

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure

by Che C. Colpitts, Thomas F. Baumert
Published 2016-08-01

Nucleic Acid-Induced Signaling in Chronic Viral Liver Disease

by Armando Andres Roca Suarez, Armando Andres Roca Suarez, Armando Andres Roca Suarez, Armando Andres Roca Suarez, Barbara Testoni, Barbara Testoni, Thomas F. Baumert, Thomas F. Baumert, Thomas F. Baumert, Thomas F. Baumert, Joachim Lupberger, Joachim Lupberger
Published 2021-02-01

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives

by Natascha Roehlen, Emilie Crouchet, Thomas F. Baumert
Published 2020-04-01

The Innate Antiviral Response in Animals: An Evolutionary Perspective from Flagellates to Humans

by Karim Majzoub, Florian Wrensch, Thomas F. Baumert
Published 2019-08-01

Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design

by Florian Wrensch, Florian Wrensch, Emilie Crouchet, Emilie Crouchet, Gaetan Ligat, Gaetan Ligat, Mirjam B. Zeisel, Mirjam B. Zeisel, Mirjam B. Zeisel, Zhen-Yong Keck, Steven K. H. Foung, Catherine Schuster, Catherine Schuster, Thomas F. Baumert, Thomas F. Baumert, Thomas F. Baumert, Thomas F. Baumert
Published 2018-06-01

Liver Abnormalities after Elimination of HCV Infection: Persistent Epigenetic and Immunological Perturbations Post-Cure

by Stephen J. Polyak, I. Nicholas Crispe, Thomas F. Baumert
Published 2021-01-01

Cell Culture Models for the Study of Hepatitis D Virus Entry and Infection

by Margaux J. Heuschkel, Thomas F. Baumert, Eloi R. Verrier
Published 2021-08-01

Hepatitis C virus infection and related liver disease: the quest for the best animal model

by Laurent eMailly, Laurent eMailly, Eric eRobinet, Eric eRobinet, Eric eRobinet, Philip eMeuleman, Thomas F. Baumert, Thomas F. Baumert, Thomas F. Baumert, Mirjam B. Zeisel, Mirjam B. Zeisel
Published 2013-07-01

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection

by Mirjam B. Zeisel, Emilie Crouchet, Thomas F. Baumert, Catherine Schuster
Published 2015-11-01

Mapping Determinants of Virus Neutralization and Viral Escape for Rational Design of a Hepatitis C Virus Vaccine

by Mei-Le Keck, Florian Wrensch, Florian Wrensch, Brian G. Pierce, Brian G. Pierce, Thomas F. Baumert, Thomas F. Baumert, Steven K. H. Foung
Published 2018-05-01

Structures and Divergent Mechanisms in Capsid Maturation and Stabilization Following Genome Packaging of Human Cytomegalovirus and Herpesviruses

by Clotilde Muller, Sophie Alain, Thomas F. Baumert, Gaëtan Ligat, Sébastien Hantz
Published 2021-02-01

Oncogenic Signaling Induced by HCV Infection

by Alessia Virzì, Armando Andres Roca Suarez, Thomas F. Baumert, Joachim Lupberger
Published 2018-10-01

Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development

by Alessia Virzì, Victor Gonzalez-Motos, Simona Tripon, Thomas F. Baumert, Joachim Lupberger
Published 2021-03-01

Viral manipulation of STAT3: Evade, exploit, and injure.

by Armando Andres Roca Suarez, Nicolaas Van Renne, Thomas F Baumert, Joachim Lupberger
Published 2018-03-01

Host-targeting therapies for hepatitis C virus infection: current developments and future applications

by Emilie Crouchet, Florian Wrensch, Catherine Schuster, Mirjam B. Zeisel, Thomas F. Baumert
Published 2018-03-01

Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein E.

by Mathieu Lefèvre, Daniel J Felmlee, Marie Parnot, Thomas F Baumert, Catherine Schuster
Published 2014-01-01

Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip

by Kaku Goto, Armando Andres Roca Suarez, Florian Wrensch, Thomas F. Baumert, Joachim Lupberger
Published 2020-04-01

Targeting the Host for New Therapeutic Perspectives in Hepatitis D

by Vincent Turon-Lagot, Antonio Saviano, Catherine Schuster, Thomas F. Baumert, Eloi R. Verrier
Published 2020-01-01